Pseudohyperkalaemia occurs when platelets, leukocytes or erythrocytes release intracellular potassium in vitro. This phenomonen was first recognized in a patient with severe thrombocytosis,' and was subsequently documented in a variety of acute and chronic myeloproliferative diseases.v" Failure to recognize pseudohyperkalaemia may lead to inappropriate potassium lowering therapy. 5 Pseudohyperkalaemia is normally identified by analysing plasma and comparing it with serum results.
We report a case where use of plasma samples gave anomalous results and correct potassium results were only obtained when fresh serum was analysed.
CASE HISTORY
An 88-year-old man was admitted with a 4-day history of feeling dizzy, unwell and weight loss of 12· 7 kg over the previous 6 months. Clinical examination on admission revealed a massive splenomegaly accompanied by a degree of hepatomegaly. A provisional diagnosis of chronic myeloid leukaemia was made.
The serum potassium concentration in a blood sample collected on admission in a tube containing no anticoagulant (Sarstedt Ltd, Leicester, UK) was 7· 1 mmol/L. There was no visible evidence of haemolysis and the sample was received and processed in the laboratory within 30 min of collection. There was no biochemical evidence of renal failure, (Table I- day I, sample 1) or diabetes mellitus (blood glucose on admission 3· 6 mmol/L). The patient was on no drugs prior to admission.
There was a gross increase in white cells (in excess of 900 x 10 9 / L, reference range 4-11 x 10 9 / L) consisting mainly of lymphocytes Correspondence: Mr I M Hembling. and prolymphocytes consistent with a diagnosis of chronic lymphocytic leukaemia.
Based on the apparent hyperkalaemia, the patient was commenced on 10 m1 of 100/0 calcium gluconate and 50 ml of 50% dextrose with 15 units of Actrapid insulin intravenously, followed by an infusion of 5% dextrose with sliding scale insulin.
The serum potassium concentration in a blood sample collected 2 h after the start of this regime was 5· 1 mmol/L (see Table I -day 2, sample 1). The dextrose/insulin infusion was stopped and the patient commenced on resonium. Further blood samples throughout the day showed mild hyperkalaemia and the clinician was advised that due to the possibility of pseudohyperkalaemia in serum samples from patients with high white cell counts,2,6,7 further blood samples for electrolyte assay should be collected into lithium heparin tubes without beads.
The potassium concentration on the first heparinized sample received on day 3 (see Table 1 ) was grossly elevated together with a sodium concentration significantly lower than that seen in the previous serum samples. The possibility of sample contamination by intravenous infusion fluids or inappropriate anticoagulants was excluded. The sample was not visibly haemolysed.
A further venepuncture was performed and 2 samples were collected, one into a tube containing no anticoagulant and the other into a tube containing lithium heparin anticoagulant. The potassium and sodium concentrations measured in the plasma sample showed marked differences from those in the serum sample (Table I- day 3, sample 2) which on this occasion had been processed and analysed immediately.
The possibility of a batch specific tube contamination was excluded by collection of a further sample into a lithium heparin tube from a different batch number (Table I- heparin tubes did not show high potassium concentration. Further blood samples collected from the patient on day 4 showed the same pattern of results. No further plasma samples were received after this date. The diagnosis of chronic lymphocytic leukaemia was confirmed and the patient was commenced on oral chlorambucil. His condition, however, deteriorated and he died some days later.
DISCUSSION
Pseudohyperkalaemia is due to leakage of intracellular potassium in vitro, and is either due to cell lysis or due to leakage from lymphocytes and platelets during clotting. This phenomenon is well recognized in a number of diseases involving proliferation of white blood cells.s-?
It isimportant to recognizepseudohyperkalaemia by measuring the potassium concentration in a concurrent plasma sample to avoid inappropriate therapy. In the case reported here, inappropriate treatment with dextrose/insulin was administered as a result of the initial failure to recognize pseudohyperkalaemia.
This patient had chronic lymphocytic leukaemia with a grossly elevated white cell count throughout the 11 day period of his hospital admission. Throughout this period we were unable to obtain reliable electrolyte results from plasma samples. In samples delivered immediately to the laboratory serum potassium concentrations were lower than in samples received after a delay. Regrettably the white cell count never fell to normal values to allow us to check serum and plasma potassium in a normal situation.
To our knowledge pseudohyperkalaemia in heparinized plasma samples from patients with leukocytosis or thrombocytosis has not previously been reported. Thrombocytosis was unlikely to be the cause of the hyperkalaemia seen in this patient as the platelet count was within the reference range.
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The patient was on no drug therapy prior to his admission and no therapy was commenced during his stay in hospital that would account for hyperkalaemia.
We therefore suggest that the abnormal elevation of plasma potassium concentration in this patient may have been due to white cell lysis as a result of some unknown interaction with lithium heparin anticoagulant. The resultant gross lysis led to marked elevation of plasma potassium concentration with a dilutional effect on plasma sodium concentration. It is suggested that there was an underlying abnormality in the lymphocytes of this individual that conferred sensitivity to lithium heparin anticoagulant.
